These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8078636)

  • 1. Shape preserving three-dimensional display of myocardial scintigraphic data.
    Loboguerrero A; Pérault C; Gibold C; Ouzan J; Pron T; Bouchard A; Lepailleur A; Liehn JC
    Nucl Med Commun; 1994 Jun; 15(6):417-21. PubMed ID: 8078636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional demarcation of perfusion zones corresponding to specific coronary arteries: application for automated interpretation of myocardial SPECT.
    Slomka PJ; Hurwitz GA; St Clement G; Stephenson J
    J Nucl Med; 1995 Nov; 36(11):2120-6. PubMed ID: 7472608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 360 degrees and 180 degrees rotation SPET acquisitions on myocardial polar map: comparison of 201Tl-, 99Tcm- and 123I-labelled radiopharmaceuticals.
    Nakajima K; Taki J; Yamamoto W; Michigishi T; Tonami N
    Nucl Med Commun; 1998 Apr; 19(4):315-25. PubMed ID: 9853321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization.
    González P; Massardo T; Muñoz A; Jofré J; Rivera A; Yovanovich J; Maiers E; Ayala F; Humeres P; Ramírez A; Arriagada M; Zavala A
    Eur J Nucl Med; 1996 Oct; 23(10):1315-22. PubMed ID: 8781135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of myocardial viability with technetium-99m hexakis-2-methoxyisobutyl isonitrile and iodine-123 phenylpentadecanoic acid and single photon emission tomography.
    Kuikka JT; Mussalo H; Hietakorpi S; Vanninen E; Länsimies E
    Eur J Nucl Med; 1992; 19(10):882-9. PubMed ID: 1451705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise gated planar myocardial perfusion imaging using technetium-99m sestamibi for the diagnosis of coronary artery disease: an alternative to exercise tomographic imaging.
    Jamar F; Topcuoglu R; Cauwe F; De Coster P; Roelants V; Beckers C; Wijns W; Melin JA
    Eur J Nucl Med; 1995 Jan; 22(1):40-8. PubMed ID: 7698154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification.
    Ceriani L; Verna E; Giovanella L; Bianchi L; Roncari G; Tarolo GL
    Eur J Nucl Med; 1996 Jan; 23(1):31-9. PubMed ID: 8586099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease.
    Narahara KA; Villanueva-Meyer J; Thompson CJ; Brizendine M; Mena I
    Am J Cardiol; 1990 Dec; 66(20):1438-44. PubMed ID: 2147536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery.
    Steg PG; Faraggi M; Himbert D; Juliard JM; Cohen-Solal A; Lebtahi R; Gourgon R; Le Guludec D
    Am J Cardiol; 1995 May; 75(15):998-1002. PubMed ID: 7747702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi.
    Garcia EV; Cooke CD; Van Train KF; Folks R; Peifer J; DePuey EG; Maddahi J; Alazraki N; Galt J; Ezquerra N
    Am J Cardiol; 1990 Oct; 66(13):23E-31E. PubMed ID: 2145742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity.
    Benoit T; Vivegnis D; Foulon J; Rigo P
    Eur J Nucl Med; 1996 Dec; 23(12):1603-12. PubMed ID: 8929314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
    Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT.
    Maunoury C; Chen CC; Chua KB; Thompson CJ
    J Nucl Med; 1997 Jun; 38(6):958-61. PubMed ID: 9189150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs.
    Leon AR; Eisner RL; Martin SE; Schmarkey LS; Aaron AM; Boyers AS; Burnham KM; Oh DJ; Patterson RE
    J Am Coll Cardiol; 1992 Dec; 20(7):1612-25. PubMed ID: 1452936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular function and myocardial perfusion during dipyridamole infusion assessed by a single injection of 99Tcm-sestamibi in patients unable to exercise.
    Takeishi Y; Sukekawa H; Saito H; Nishimura S; Shibu T; Sasaki Y; Tomoike H
    Nucl Med Commun; 1994 Sep; 15(9):697-703. PubMed ID: 7816382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of rest technetium-99m sestamibi SPET and low-dose dobutamine stress echocardiography for the early assessment of myocardial viability after acute myocardial infarction: importance of the severity of the infarct-related stenosis.
    Claeys MJ; Rademakers FE; Vrints CJ; Krug B; Bosmans JM; Conraads V; Bossaert LL; Snoeck JP; Blockx PP
    Eur J Nucl Med; 1996 Jul; 23(7):748-55. PubMed ID: 8662112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.